US EditionDebate over the abortion pill mifepristone resurfaces after new FDA chief confirmed
- Dr. Marty Makary was confirmed by the Senate to lead the Food and Drug Administration on Tuesday.
- Medical professionals state that mifepristone is 97.4% effective for completed abortions, according to U.S. Studies.
- A legal brief states that serious adverse events occur in less than 0.32% of patients taking mifepristone, based on a study with over 50,000 patients.
- Dr. Pratima Gupta noted that for procedural abortions, the chance of failure is probably less than 0.1%.
Insights by Ground AI
Does this summary seem wrong?
72 Articles
72 Articles
All
Left
4
Center
59
Right
2
Helena Independent Record+39 Reposted by 39 other sources
Debate over the abortion pill mifepristone resurfaces after new FDA chief confirmed
A pill used in most U.S. abortions has been ensnared in politics for years, and many Americans wonder whether it will be restricted under the new Republican administration.
·Helena, United States
Read Full Article
MedPage TodayReposted by 
Anti-Aging, Acupuncture and Health News
Anti-Aging, Acupuncture and Health NewsDebate Over Abortion Pill Resurfaces After Makary Is Confirmed to Head FDA
(MedPage Today) -- Many Americans wonder whether the pill used in most U.S. abortions will be restricted under the new Republican administration in Washington. President Donald Trump's pick to lead the FDA, Marty Makary, MD, MPH, was confirmed...
·New York, United States
Read Full Article
Coverage Details
Total News Sources72
Leaning Left4Leaning Right2Center59Last UpdatedBias Distribution91% Center
Bias Distribution
- 91% of the sources are Center
91% Center
C 91%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
